L Ratiani1,2, V Shoshiashvili1,2*, E Vashakidze1,2, M Rurua1,2, E Pachkoria1,2, E khuchua1, L Gabunia1,2 and K Machavariani1,2
1First University Clinic of Tbilisi State Medical University, Georgia
2Tbilisi State Medical University, Georgia
*Corresponding Author: V Shoshiashvili, First University Clinic of Tbilisi State Medical University, Georgia.
Received: July 16, 2021; Published: September 08, 2021
Coronavirus disease-2019 (COVID-19) caused by coronavirus 2 (SARS-CoV-2) infection is a global health problem; Severe COVID-19 can lead to multi-organ failure and may be associated with high mortality. The incidence and outcomes of COVID-19 in immunocompromised patients are a matter of debate, clinical presentation and management of liver injury in liver transplant patients with COVID -19 is unclear and may be an increasing challenge for the transplant centers. This is a Case report from Georgia that presents a case of COVID-19 in a patient with a liver transplant. Due to Corticosteroids and Antibiotic therapy, in parallel with continuing immunosuppressive drug full recovery was achieved. His maintenance immunosuppressive therapy includes calcineurin inhibitor (Cyclosporine) 75 mg BID, which was not ceased.
Keywords: COVID-19; Liver Transplantation; Immunosuppressants; Management
Citation: V Shoshiashvili., et al. “COVID 19 in Liver Transplant Patient - Case Report”.Acta Scientific Medical Sciences 5.10 (2021): 34-37.
Copyright: © 2021 V Shoshiashvili., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.